Sentinel node biopsy: Who needs it?

International Journal of Dermatology

Volumn 39, Issue 11, 2000, Pages 807-811

  Coldiron, Brett M ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; INTERFERON;

CANCER ADJUVANT THERAPY; CANCER STAGING; DIAGNOSTIC VALUE; DOSE RESPONSE; EXCISION; HUMAN; LYMPH NODE DISSECTION; MELANOMA; METASTASIS; PREDICTION; REVIEW; SURVIVAL RATE; TUMOR BIOPSY;

HUMANS; SENTINEL LYMPH NODE BIOPSY;

EID: 0034528756     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2000.00055.x     Document Type: Review

References (43)

1. Intraoperative lymphatic mapping and sentinel lymphadenectomy: Community standard care or clinical investigation?
2. An approach for the treatment of penile carcinoma
3. Sentinel lymph node dissection for penile carcinoma: The M.D. Anderson Cancer Center experience
4. Controversies in ilioinguinal lymphadenectomy for cancer of the penis
5. Role of lymphadenectomy in carcinoma of the penis
6. Cabanas approach: Is sentinel node biopsy reliable for staging penile carcinoma?
7. Carcinoma of the penis: An 11-year review
8. Detection of occult metastasis in squamous cell carcinoma of the penis using a dynamic sentinel node procedure
9. Randomized surgical trials involving elective node dissection for melanoma
10. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomized trial
11. Lymphadenectomy in the management of stage I malignant melanoma: A prospective randomized study
12. Inefficacy of immediate node dissection in stage I melanoma of the limbs
13. Efficacy of an elective regional lymph node dissection of I-4 mm thick melanomas for patients 60 years of age and younger
14. Lymphatic drainage of skin to a sentinel lymph node in a feline model
15. Location of sentinel lymph nodes in patients with cutaneous melanoma: New insights into lymphatic anatomy
16. Lymph node localization in malignant melanoma
17. Melanoma of the trunk: The results of surgical excision and anatomic guidelines for predicting nodal metastasis
18. Reproducibility of lymphoscintography for lymphatic mapping in cutaneous melanoma
19. Sentinel node biopsy for melanoma in the head and neck region
20. Discordancy between clinical predictions vs lymphoscintographic and intraoperative mapping of sentinel lymph node drainage of primary melanoma
21. Will the true sentinel node please stand?
22. Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients
23. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma
24. Outcome of patients with melanoma and histologically negative sentinel lymph nodes
25. Pathologic examination of the sentinel lymph node in malignant melanoma
26. Detection of tyrosinase mRNA by reverse transcription polymerase chain reaction in melanoma sentinel nodes
27. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction early stage melanoma patients
28. Nodal nevi are frequent and selectively located in melanoma draining nodes: Implications for their etiology
29. Sentinel lymph node biopsy in breast cancer: Initial experience at Memorial Sloan-Kettering Cancer Center
30. Sentinel node biopsy in breast cancer: Arguments for node biopsy are weak
31. Use of the sentinel lymph node to determine metastases of gastrointestinal malignancies: A world of caution
32. Sentinel node biopsy in breast cancer
33. Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms
34. Lymphatic mapping and selective lymphadenectomy for melanoma: Not yet standard therapy
35. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group trial test 1684
36. Randomized trial of interferon alfa-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases
37. Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma
38. Pooled analysis of the efficacy of bacille Calmette-Guérin (bcg) immunotherapy in malignant melanoma
39. Lymphatic mapping and sentinel lymphadenectomy after wide local excision of primary melanoma
40. Sentinel node biopsy before and after wide excision of the primary melanoma
41. Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma
42. Molecular staging of malignant melanoma